Clinical Trials Browser

Phase 1 × Valganciclovir × 90 days × Clear all

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult